Comparing Cosmos Health (NASDAQ:COSM) and BetterLife Pharma (OTCMKTS:BETRF)

Cosmos Health (NASDAQ:COSM) and BetterLife Pharma (OTCMKTS:BETRF) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their risk, institutional ownership, earnings, dividends, valuation, analyst recommendations and profitability.

Institutional and Insider Ownership

12.6% of Cosmos Health shares are owned by institutional investors. Comparatively, 0.0% of BetterLife Pharma shares are owned by institutional investors. 25.1% of Cosmos Health shares are owned by company insiders. Comparatively, 34.8% of BetterLife Pharma shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Valuation & Earnings

This table compares Cosmos Health and BetterLife Pharma”s revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cosmos Health	$54.43 million	0.59	-$16.18 million	($1.03)	-1.01
BetterLife Pharma	N/A	N/A	-$2.55 million	N/A	N/A

BetterLife Pharma has lower revenue, but higher earnings than Cosmos Health.

Volatility & Risk

Cosmos Health has a beta of 5.36, meaning that its share price is 436% more volatile than the S&P 500. Comparatively, BetterLife Pharma has a beta of 1.16, meaning that its share price is 16% more volatile than the S&P 500.

Profitability

This table compares Cosmos Health and BetterLife Pharma’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Cosmos Health	-27.90%	-18.32%	-8.60%
BetterLife Pharma	N/A	N/A	-351.45%

Analyst Ratings

This is a breakdown of current ratings and recommmendations for Cosmos Health and BetterLife Pharma, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Cosmos Health	1	0	0	0	1.00
BetterLife Pharma	0	0	0	0	0.00

Summary

Cosmos Health beats BetterLife Pharma on 5 of the 9 factors compared between the two stocks.

About Cosmos Health

Cosmos Health Inc. manufactures, develops, and trades branded nutraceutical products in Greece, the United Kingdom, Croatia, Bulgaria, Cayman Islands, and Cyprus. It offers medicines, OTC medicines, nutraceutical products, vitamins, minerals and dietary, health care products, medical devices, baby products, and others under the Sky Premium Life and Mediterranation brand names. The company serves wholesale distributors and other healthcare providers, such as clinics, government agencies, independent retail and specialty pharmacies and independent specialty distributors. It sells its products through independent wholesale distributors. Cosmos Health Inc. was incorporated in 2009 and is headquartered in Chicago, Illinois.

About BetterLife Pharma

BetterLife Pharma Inc., a biotechnology company, engages in the development and commercialization of compounds for the treatment of mental disorders in Canada. It is also involved in refining and developing drug candidates from a set of complementary interferon-based technologies that have the potential to engage the immune system to fight virus infections. The company's products pipeline includes BETR-001 for the treatment of major depressive disorder, anxiety, and neuropathic pain and other neuro-psychiatric and neurological disorders; and BETR-002 to treat benzodiazepine dependency, anxiety, and neurodegenerative disorders. It is also developing MM-003, which has completed Phase II clinical trials for treatment of COVID-19 and other respiratory viral infections; and MM-001, a topical cream for local intravaginal use to treat HPV-induced cervical intraepithelial neoplasia that has completed Phase II clinical trials. The company was formerly known as Pivot Pharmaceuticals Inc. and changed its name to BetterLife Pharma Inc. in December 2019. BetterLife Pharma Inc. was incorporated in 2002 and is headquartered in Vancouver, Canada.